Synthesis and pharmacological profile of a series of 2,5substituted-N,N-dimethyltryptamine derivatives as novel antagonists for the vascular 5-HT1B-like receptor

Journal of the Chemical Society - Perkin Transactions 1

Volumn , Issue 19, 1999, Pages 2713-2723

  Moloney, Gérard P ^a   Martin, Graeme R ^a   Mathews, Neil ^a   Hobbs, Heather ^b   Dodsworth, Susan ^b   Sang, Pang Yih ^b   Knight, Cameron ^a   Maxwell, Miles ^a   Glen, Robert C ^b  

^a MONASH UNIVERSITY   (Australia)

^b ROCHE BIOSCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002506247     PISSN: 0300922X     EISSN: None     Source Type: Journal    
DOI: 10.1039/a903328i     Document Type: Article

References (58)

1. G.A. Glennon and M. Dukat, Serotonin Receptor Subtypes, in Psychopharniacology: Tlie Fourth Generation of Progress; ed. F. Bloom and M. Kupfer, Raven Press: New York, 1994; pp. 415429.
2. (a) G.R. Martin and P. P. A. Humphrey, Neuropharmacolo'qy, 1994, 33,261;
3. (b) D. Hoyer, D.E. Clarke, J. R. Fozard, P. R. Hartig, G. R. Martin, E. J. Mylecharane, P. R. Saxena and P. Humphrey, 'Pharmacol. Rev., 1994,46, 157.
4. F. Saudou and R. Hen, Mal. Chcm. Res., 1994,4, 16.
5. P.P. A. Humphrey, P. Hartig and D. A. Hoyer, Trends Pharmacol. Sci., 1993,14, 233.
6. D. Julius, Anmi. Re\: Neurosci., 1991, 14, 335.
7. P.R. Hartig, H. T. Kao, M. Macchi, N. Adham, J. Zgombick, R. Weinshank and T. Branchek, Neuropsychopharmacoloqy, 1990,3, 335.
8. A. Frazer, S. Maayani and B.B. Wolfe, Anmi. Rcv. Pharmacol. raxicoi, 1990,30, 307.
9. A.W. Schmidt and S. J. Peroutka, FASEBJ., 1989,3, 2242.
10. S.J. Peroutka, Trends. Neurosci., 1988,11,496.
11. H. Matthes, U. Beschert, N. Amliaky, R. Grailhe, J. Plassat, F.G. Muscatelli and R. Hen, Mol. Pharmacol., 1993,43, 313.
12. F.J. Monsma, Y. Shen, R. P. Ward, M. W. Hamblin and D. R. Sibley, Mol. Pharmacol., 1993,43, 320.
13. Y. Shen, F.J. Monsma, M. A. Metcalf, P. A. José, M. W. Hamblin and D. R. Sibley, J. Biol. Cliem., 1993,268, 18200.
14. C. Waeber, P. Schoeffter, D. Hoyer and J.M. Palacios, Neurochein. Res., 1990,15,567.
15. P.P. A. Humphrey, W. Feniuk, M. J. Perren, H. E. Connor, A. W. Oxford, I. H. Coates-ahd D. Butina, Dr. J. Pharmacol, 1988, 94, 1123.
16. R.L. Weinshank, J. Zgombick, M. J. Macchi, T. A. Branchek and P. R. Hartig, Proc. Natl. Acad. Sci. U.S.A., 1992,89, 3630.
17. (a) M.D. Ferrari and P. R. Saxena, Trends. Pharmacol. Sci., 1993, 14, 129;
18. (b) K.L. Dechant and S. P. Clissold, Drugs, 1992,43, 776.
19. R.C. Glen, A. P. Hill, G. R. Martin and A. D. Robertson, Headache, 1994,34,307.
20. R.C. Glen, G. R. Martin, A. P. Hill, R. M. Hyde, P. M. Woollard, J. A. Salmon, J. Buckingham and A. D. Robertson, J. Mal. Client., 1995,38, 3566.
21. L.J. Street, R. Baker, J. L. Castro, M. S. Chambers, A. R. Guiblin, S. C. Hobbs, V. G. Matassa, A. J. Reeve, M. S. Beer, D. N. Middlemiss, A. J. Noble, J. A. Stanton, K. Scholey and R. J. Hargreaves, J. Med. Chem., 1993,36, 1529.
22. J.L. Castro, R. Baker, A. R. Guiblin, S. C. Hobbs, M. R. Jenkins, M. G. N. Russell, M. S. Béer, J. A. Stanton, K. Scholey, R. J. Hargrea%-es, M. I. Graham and V. G. Matassa, J. Med. Chem., 1994, 37, 3023.
23. J.E. Macor, D. H. Blank, C. B. Fox, L. A. Lebel, M. E. Newman, R. J. Post, K. Ryan, A. W. Schmidt, D. W. Schultz and B. K. Koe, J. Med. Chem., 1994,37, 2509.
24. (a) European Patent EP 0 533 266 AI, 1992;
25. (b) European Patent EP 0 533 267 AI, 1992;
26. European Patent EP 0 533 268 AI, 1992.
27. J.W. Clitherow, D. I. Scopes, M. Skingle, C. C. Jordan, W. Feniuk, I. B. Campbell, M. C. Carter, E. W. Collington, H. E. Connor, G. A. Higgins, D. Beattie, H. A. Kelly, W. L. Mitchell, A. W. Oxford, A. H. Wadsworth and M. B. Tyers, J. Med. Chem., 1994,37, 2253.
28. D.M. Walsh, D. T. Beattie and H. E. Connor, Ew. J. Pharmacol., 1995, 287, 79.
29. G.P. Moloney, A. D. Robertson, G. R. Martin, S. MacLennan, N. Mathews, S. Dodsworth, Pane Yih Sane, C. Knight and R. C. Glen, J. Med Chem., 1997,40, 2347.
30. G.P. Moloney, G. R. Martin, N. Mathews, H. Hobbs, S. Dodsworth, Pang Yih Sang, C. Knight, M. Williams, M. Maxwell and R. C. Glen, J. Med Chem., 1998, submitted.
31. A. Maseri, Circulation, 1990,11-13.
32. D.J. Fitzgerald, L. Roy, F. Catella and G. A. Fitzgerald, Neu: Engl. J. Med., 1986,315,983.
33. P.B. Bradley, G. Engel, W. Feniuk, J. R. Fozard, P. P. A. Humphrey, D. N. Middlemiss, E. J. Mylecharane, B. P. Richardson and P. R. Saxena, Neiiropharmacology, 1986, 25, 563.
34. A.L. Scherbel and J. N. HarHson, Angiology, 1959,10, 29.
35. E.P. McFadden, J. G. Clarke, G. J. Davies, J. C. Kaski, A. W and M. A. Maseri, New. Engt. J. Med, 1991,324, 648.
36. P. Golino, F. Piscione, J.T. Willerson, M. Cappelli-Bigazzi, A. Focaccio, B. Villari, C. Indolfi, E. Russolillo, M. Condorelli and M. Chiariello, A'cir. Engl. J. Med., 1991,324, 641.
37. D.D. Heistad, M. L. Armstrong, M. L. Marcus, D. J. Piegors and A. L. Mark, Circ. Res., 1984,54, 711.
38. A. Verheyen, F. Lauwers, E. Vlaminckx, L. Wouters and F. De Clerck, s of the 5th Meeting of the Belgian Cardiology Society, pA7, 1987.
39. N.K. Hollenberg, K. Monteiro and T. Sandor, J. Pharmacol. Exp. Ther., 1988,244, 1164.
40. R.G. Schaub, K. M. Meyers and R. D. Sande, J. Lab. Clin. Med., 1977,90,645.
41. F. De Clerck, W. Loots, A. Jageneau and A. Nevelsteen, Drug. De\: Res., 1986,8, 149.
42. C. Orlandi, J.L. Blackshear and N. K. Hollenberg, Microvase. Res., 1986,32,121.
43. R.R. Phillips, Org. React., 1959,10, 143.
44. F.R. Japp and P. Klincemann, in Methoden der organischen Chemie, (Houben-Weyl-Mullerj Bd. Xβ, S.523, Thieme-Verlag, Stuttgart 1965.
45. E.B. Cantrell and D. M. Zimmerman, Eli Lilly and Co, European Patent, EP 0506 478 A1, 1992.
46. P. Pevarcllo and M. Varasi, Synth. Commun., 1992, 22, 1939.
47. D.M. Vyas, Y. Chiang and T. W. Doyle, Tetrahedron Lett., 1984, 25, 487.
48. (a) P. Grunanger and P. Vita Finzi, Isoxaioles. Pan 1 in The Chemistry of Hcterocyclic Compounds, ed.E. C. Taylor, Wiley, New York, 1990; pp. 196-207;
49. (b) M.C. Ashraf, T. J. Burrowes and W. R. Jackson, Aust. J. Cliem., 1976, 29, 2643;
50. G. Stagno D'Alcontres and G. Lo Vecchio, Ga::. Cliim. Hal., 1960,90, 1239.
51. A.R. Gagneux, F. Haniger, C. H. Eugster and R. Good, Tetrahedron Lett., 1965, 2077.
52. G.S. Skinner, J. Am. Cliem. Soc., 1924,46, 731.
53. G.P. Moloney, G. R. Martin, N. Mathews, H. Hobbs, S.
54. Dodsworth, Pang Yih Sang, C. Knight, M. Maxwell and R.C. Glen, J. Chcm. Soc., Pcrkin Trails. 1, 1999, 2699.
55. G.R. Marshall, C. D. Barry, H. E. Bosshard, R. A. Dammkoehlcr and D. A. Dünn, The Confornuilional Parameter in Drug-Design: Active Analogue Approach, Computer Assisted Drug Design; ACS Symposium series 112, American Chemical Society: Washington DC, 1979.
56. G.R. Martin and S. J. MacLennan, Naunyn - Schmicdcbergs. Arch. Pharmacol, 1990,342, 111.
57. S.J. MacLennan and G. R. Martin, Br. J. Pharm., 1992,107,418.
58. Sybyl 6.1 molecular modelline package. Tripos Associates, St Louis MO 63144, U.S.A. 1992.